Our technology

Building Transformative Therapeutics Through Simulation

The unparalleled accuracy of our technology grants unprecedented insights into drug mechanisms, allowing us and our partners to pursue truly groundbreaking therapeutic strategies.

Learn More

Our Mission

Unlocking Undruggable Targets

Our core technology has been built to succeed where status quo in-silico drug design fails. We’ve raised the bar for simulation accuracy, putting previously inaccessible targets and modalities into play.

About Us

Recent News & Events

October 29, 2025

Dr. Anthony Fejes will be presenting HTuO’s poster at Drug Discovery Chemistry Europe. Come by poster B11 on Wednesday, November 12th in the afternoon to learn about HTuO’s recent work.

October 8, 2025

Our CEO, Dr. Anthony Fejes will be in Barcelona, Spain Nov 11-13 at Drug Discovery Chemistry Europe presenting a poster. Connect with Anthony or email us directly to learn about HTuO and our drug discovery goals.

September 2, 2025

HTuO Biosciences today announced a strategic research collaboration with Micrographia Bio, a UK based biotechnology company. The collaboration, funded by the Canadian Government, will combine Spatial Proteomics and CADD tools to develop a next-generation small molecule osteoporosis drug.

View All News & Events
Team Image

Interested in working with us?

Join the HTuO Team

Check our Careers page for open positions, and see if we have the right opportunity for you.

Open Positions